Proton pump inhibitors have been a cornerstone in the treatment of gastresophageal reflux disease and peptic ulcer disease since their introduction in the late 1980s. Gastresophageal reflux disease is a common disorder, and 12.4 million prescriptions for proton pump inhibitors were dispensed in
No takes yet. Share an insight, caveat, or question.
Richards et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: